期刊簡(jiǎn)介預(yù)計(jì)審稿時(shí)間： 約1月

EJCI considers any original contribution from the most sophisticated basic molecular sciences to applied clinical and translational research and evidence-based medicine across a broad range of subspecialties. The EJCI publishes reports of high-quality research that pertain to the genetic, molecular, cellular, or physiological basis of human biology and disease, as well as research that addresses prevalence, diagnosis, course, treatment, and prevention of disease. We are primarily interested in studies directly pertinent to humans, but submission of robust in vitro and animal work is also encouraged. Interdisciplinary work and research using innovative methods and combinations of laboratory, clinical, and epidemiological methodologies and techniques is of great interest to the journal. Several categories of manuscripts (for detailed description see below) are considered: editorials, original articles (also including randomized clinical trials, systematic reviews and meta-analyses), reviews (narrative reviews), opinion articles (including debates, perspectives and commentaries); and letters to the Editor.

EJCI 考慮從最復(fù)雜的基礎(chǔ)分子科學(xué)到廣泛分支學(xué)科的應(yīng)用臨床和轉(zhuǎn)化研究以及循證醫(yī)學(xué)的任何原創(chuàng)貢獻(xiàn)。EJCI 發(fā)表與人類生物學(xué)和疾病的遺傳、分子、細(xì)胞或生理基礎(chǔ)有關(guān)的高質(zhì)量研究報(bào)告，以及涉及疾病的流行、診斷、過程、治療和預(yù)防的研究。我們主要對(duì)與人類直接相關(guān)的研究感興趣，但也鼓勵(lì)提交可靠的體外和動(dòng)物研究。該期刊非常重視使用創(chuàng)新方法以及實(shí)驗(yàn)室、臨床和流行病學(xué)方法和技術(shù)組合的跨學(xué)科工作和研究。幾類稿件（詳細(xì)描述見下文）將被考慮：社論、原創(chuàng)文章（還包括隨機(jī)臨床試驗(yàn)、系統(tǒng)評(píng)價(jià)和薈萃分析）、評(píng)論（敘述性評(píng)論）、意見文章（包括辯論、觀點(diǎn)和評(píng)論）；以及致編輯的信。

《European Journal Of Clinical Investigation》(歐洲臨床研究雜志)編輯部通訊方式為WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148。如果您需要協(xié)助投稿或潤(rùn)稿服務(wù)，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務(wù)十年，熟悉發(fā)表政策，可為您提供一對(duì)一投稿指導(dǎo)，避免您在投稿時(shí)頻繁碰壁，節(jié)省您的寶貴時(shí)間，有效提升發(fā)表機(jī)率，確保SCI檢索（檢索不了全額退款）。我們視信譽(yù)為生命，多方面確保文章安全保密，在任何情況下都不會(huì)泄露您的個(gè)人信息或稿件內(nèi)容。